Valeant Pharmaceuticals Intern… (NYSE:VRX)

Major Biopharma Catalysts on October’s FDA Calendar

Companies in the biotech and pharmaceutical industries are subject to a sizable amount of risk with regards to their drug candidates passing clinical trials and gaining regulatory approval. But with ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Dollar General, KLA-Tencor, Micron Technology, Nike, Red Hat and More

The futures traded higher Friday morning, although it appears that the worries over trade and tariffs are still in place. This comes despite the fact that car makers in Europe ...
Read Full Story »

Valeant Pharmaceuticals Woes Continue as FDA Fails to Approve Plaque Psoriasis Lotion

If any company has had a tough past three years it has been Valeant Pharmaceuticals International Inc. (NYSE: VRX). The company has gone from a Wall Street darling, and a ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Alkermes, Cigna, International Paper, Medtronic, Tesla, Western Digital and More

The futures traded higher again Wednesday morning, perhaps in part because of the fact that the Russell 2000 hit an all-time high on Tuesday. That is a move that no ...
Read Full Story »

Top Analyst Upgrades and Downgrades: CBS, Ford, Pivotal Software, Spotify, Symantec, Ulta Beauty and More

The futures traded lower Tuesday morning on some renewed trade worries and perhaps profit-taking. The Dow Jones industrial average was able to rack up its eighth day in a row ...
Read Full Story »

4 Specialty Pharma Stocks That Deutsche Bank Likes for the Rest of 2018

While large cap pharmaceutical stocks have had a very solid year despite the rumbling by the administration over drug pricing, many smaller specialty pharmaceuticals have lagged. Despite that underperformance, some ...
Read Full Story »

What Will Become of Valeant Pharmaceuticals?

Valeant Pharmaceuticals International Inc. (NYSE: VRX) released its most recent quarterly report before the markets opened on Tuesday. At the same time, the firm announced that it would also be ...
Read Full Story »

Disney, Groupon, Nvidia and More Major Earnings Coming This Week

The U.S. broad markets rallied on Friday to close roughly even, although slightly lower, making this second consecutive week with a loss (excluding the Nasdaq). These past two weeks have ...
Read Full Story »

The Top Biopharma Catalysts Coming in May

Biotech and pharmaceutical companies are generally involved in the lengthy process of getting their drug candidates to market through clinical trials. The amount of risk involved ranges from fair to ...
Read Full Story »

Top Analyst Upgrades and Downgrades: ADM, Boeing, Hess, LogMeIn, NetApp, Sunrun, United Continental, Valeant, XPO and More

Stocks were weak on Friday morning ahead of the unemployment and payrolls report, due to an expanded potential of $100 billion more in tariffs against China. The market has been ...
Read Full Story »

Deutsche Bank Out With New Top Stock Buys for the Next Year

With the first quarter of 2018 over, and a rash of earnings reports ready to hit the tape, many of the top firms we cover here at 24/7 Wall St. ...
Read Full Story »

Does Deutsche Bank Finally Have It Right on Valeant?

Valeant Pharmaceuticals International Inc. (NYSE: VRX) shares saw a handy gain on Monday after one key analyst upgraded the stock. The company posted its fourth-quarter results last week, and investors ...
Read Full Story »

Top Analyst Upgrades and Downgrades: AMAG, Foot Locker, Groupon, H&R Block, McDonald’s, Teradata, Under Armour, Valeant and More

Stocks were indicated marginally lower on Monday morning, with more worries of trade wars after steel and aluminum tariffs. The Dow Jones industrial average was indicated to open under 24,500 and ...
Read Full Story »

Why Valeant Pharmaceuticals Shares Are Backing Way Off

When Valeant Pharmaceuticals International Inc. (NYSE: VRX) reported its most recent quarterly results before the markets opened on Wednesday, the company said that it had $0.98 in earnings per share ...
Read Full Story »

Square, Salesforce and More Big Earnings to Watch This Week

In the past week, markets have recovered slightly after being largely driven lower as the result of a sharp increase in volatility. All three major exchanges gained on average less ...
Read Full Story »